Smoking Cessation Intervention for Diabetic Patients

Completed · Not applicable

Conditions studied: Smoking, Type 2 Diabetes

In brief

This study is designed to develop and test a smoking cessation intervention for smokers with Type 2 diabetes.

Key facts

Study ID

NCT01501877

Run by

Rhode Island Hospital

People needed

20

Starts

2011-12-01

Expected to finish

2016-06-01

Last updated by the study team

2017-04-12

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 21 years of age or older
• Type 2 diabetes
• regular smoker for at least 3 years
• smoke an average of more than 10 cigarettes per day
• report motivation to quit smoking of at least 5 out of 10
• speak English

You may not qualify if…

• current alcohol abuse or dependence
• current substance abuse or dependence (excluding nicotine)
• psychotic
• form of diabetes other than Type 2
• medical condition that is a contraindication for the transdermal nicotine patch
• using pharmacotherapy for smoking cessation
• using other tobacco products
• unable to provide names and contact information for locators
• no access to a telephone

Where it is running

• Rhode Island Hospital — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.